ELV
Elevance Health·NYSE
--
--(--)
--
--(--)
4.68 / 10
Netural
Liquidity flow evaluation: 7.87/10 demonstrating robust fund flow characteristics. Optimistic overall, block, Medium, Large, and Extra-large patterns are mitigated by pessimistic Small indicators, pointing to positive flow perspective. Research analyst consensus shows overwhelmingly bullish analyst consensus, demonstrating strong conviction. Current ratings: Strong Buy(50.0%), Buy(50.0%) across 6 coverage providers, supported by 1.49 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-30
InstitutionBarclays
Times predicted10
Historical Win Rate40.0%
What is the market sentiment for ELV?
- ELV holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.68/10 (Netural).
